Search results
Showing 61 to 75 of 659 results for position
Evidence-based recommendations on Synergo for non-muscle-invasive bladder cancer.
View recommendations for MTG61Show all sections
Uterine prolapse happens when the uterus (womb) slips from its normal position and bulges or hangs down into the vagina. This can cause...
a Clinical Division NICE assurance system is described moving - from a position of poor processes and ineffective evaluation strategies...
Tocilizumab for the treatment of rheumatoid arthritis (TA247)
Evidence-based recommendations on tocilizumab (RoActemra) for treating rheumatoid arthritis in adults.
This guideline covers managing spasticity and co-existing motor disorders and their early musculoskeletal complications in children and young people (from birth up to their 19th birthday) with non-progressive brain disorders. It aims to reduce variation in practice and help healthcare professionals to select and use appropriate treatments.
Summary of the evidence on fludrocortisone for treating postural hypotension in adults to inform local NHS planning and decision-making
Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)
Evidence-based recommendations on ticagrelor (Brilique) for preventing atherothrombotic events after myocardial infarction in adults.
director of innovation for Manchester University NHS Foundation Trust (MFT), a position she has held since April 2020. This role...
Our methods and processes (health technology evaluation manual)
how we develop this guidance Methods and processes used before 2022 Position statements Taking a proportionate approach to technology...
Open reduction of slipped capital femoral epiphysis (IPG511)
Evidence-based recommendations on open reduction of slipped capital femoral epiphysis. This involves fixxing a slipped capital femoral epiphysis back into its correct position to reduce the risk of avascular necrosis.
View recommendations for IPG511Show all sections
Deucravacitinib for treating moderate to severe plaque psoriasis (TA907)
Evidence-based recommendations on deucravacitinib for treating moderate to severe plaque psoriasis in adults.
This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications.
Constipation in children and young people: diagnosis and management (CG99)
This guideline covers diagnosing and managing constipation in children and young people up to 18. It provides strategies to support the early identification and timely, effective treatment of constipation which will help improve outcomes for patients. It does not cover constipation caused by a specific condition.
Unintentional injuries on the road: interventions for under 15s (PH31)
This guideline covers road speed limits, 20 mph zones and engineering measures to reduce speed or make routes safer.
View recommendations for PH31Show all sections
Sections for PH31
- Introduction
- 1 Recommendations
- 2 Public health need and practice
- 3 Considerations
- 4 Recommendations for research
- 5 References
- Appendix A: Membership of the Public Health Interventions Advisory Committee (PHIAC), the NICE project team and external contractors
- Appendix B: Summary of the methods used to develop this guidance
Fulvestrant for the treatment of locally advanced or metastatic breast cancer (TA239)
Evidence-based recommendations on fulvestrant (Faslodex), for treating locally advanced or metastatic breast cancer in adults.